收藏切换
Clinical trial on effects of infection on prognosis of patients with ST segment elevation myocardial infarction
收藏切换
PDF
Li-shan ZHU1, Wen-xin GAO1, Jia-ying LI1, Jing LIANG2
Chinese Journal of Clinical Pharmacology | 2025, 41(17) : 2407 - 2411
Less
收藏切换
Chinese Journal of Clinical Pharmacology | 2025, 41(17): 2407-2411
Clinical and Basic Bridging Research
Clinical trial on effects of infection on prognosis of patients with ST segment elevation myocardial infarction
Full
Li-shan ZHU1, Wen-xin GAO1, Jia-ying LI1, Jing LIANG2
Affiliations
  • 1.Department of Cardiovascular Medicine/Institute of Gerontology, The Second Medical Center of PLA General Hospital, Beijing 100143, China
  • 2.Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China
Published: 2025-09-17 doi: 10.13699/j.cnki.1001-6821.2025.17.002
Outline
收藏切换
Objective

To develop and validate a simple scoring system for predicting the risk of infection after acute myocardial infarction (AMI) in patients undergoing percutaneous coronary intervention (PCI).

Methods

Continuous patients with ST-segment elevation myocardial infarction (STEMI) who received PCI in our hospital were divided into training set and validation set using a cohort approach. All patients received oral rosuvastatin calcium tablets 10-20 mg per day combined with evolocumab injection therapy 140 mg. The primary endpoint was post-AMI infection during hospitalization, while all-cause mortality and major adverse cardiovascular events (MACE) were considered secondary endpoints. The area under the curve (AUC) and the calibration between predicted and observed infection risks were calculated. A backward stepwise logistic regression model was selected to develop the risk score.

Results

A total of 359 patients were included, with 217 in the training set and 142 in the validation set, and no patient dropout occurred during the study. A 24-point risk scoring system was developed, with infection risks ranging from 0.70% to 99.60% in patients with the lowest and highest scores, respectively. Seven variables including age, Killip class, insulin use, white blood cell count, serum albumin, diuretics and transfemoral approach were incorporated into the model. The model achieved equally high discrimination in both the development and validation cohorts (C-statistic: 0.85) and demonstrated good calibration in both datasets. In both development and validation cohorts, the incidence of post-myocardial infarction infection increased steadily across risk score groups. Additionally, this risk score exhibited good predictive ability for infection, in-hospital all-cause mortality.

Conclusion

This study established a simple bedside tool, a risk scoring system for assessing the risk of infection and other in-hospital outcomes in STEMI patients undergoing PCI. Clinicians can utilize this risk scoring system to evaluate infection risk and make evidence-based decisions accordingly.

rosuvastatin calcium tablet  /  evolocumab injection  /  percutaneous coronary intervention  /  acute myocardial infarction  /  hospital-acquired infection
Li-shan ZHU, Wen-xin GAO, Jia-ying LI, Jing LIANG. Clinical trial on effects of infection on prognosis of patients with ST segment elevation myocardial infarction[J]. Chinese Journal of Clinical Pharmacology, 2025 , 41 (17) : 2407 -2411 . DOI: 10.13699/j.cnki.1001-6821.2025.17.002
Year 2025 volume 41 Issue 17
PDF
172
35
Cite this Article
BibTeX
Article Info
doi: 10.13699/j.cnki.1001-6821.2025.17.002
  • Receive Date:2025-08-15
  • Online Date:2026-08-05
  • Published:2025-09-17
Article Data
Affiliations
History
  • Received:2025-08-15
Funding
Affiliations
    1.Department of Cardiovascular Medicine/Institute of Gerontology, The Second Medical Center of PLA General Hospital, Beijing 100143, China
    2.Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China
References
Share
https://castjournals.cast.org.cn/joweb/zglcylxzz/EN/10.13699/j.cnki.1001-6821.2025.17.002
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT